Logiscreen

NeuroPace Inc

$15.74
Market Cap 529.92M
ROE -120.7%
Gross Margin 81.8%
Debt/Equity 4.9
Current Ratio 5.4
Revenue QoQ -2.0%
EPS QoQ -0.0%
F-Score 3

About

Based in Mountain View, Calif., NeuroPace is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of debilitating seizures. Its novel and differentiated RNS System is the first and only commercially available, brain-responsive platform that delivers personalized, real-time treatment at the seizure source. This platform can drive a better standard of care for patients living with drug-resistant epilepsy and has the potential to offer a more personalized solution and improved outcomes to the large population of patients suffering from other brain disorders.

Exchange
NASDAQ
Sector
Healthcare
Industry
Medical Devices

Sector context

Healthcare

Undervalued

Trading at a discount to sector peers

P/E
-25.48
vs median 33.61
P/B
38.01
vs median 2.16
ROE
-1.21
vs median 0.09

Lower quality - review fundamentals carefully

Small-cap company with higher volatility

Similar companies

Primary metric
Overlay metric
Loading chart data...
Fetching latest financial metrics